More than 800 Advocates, Pharmaceutical Companies, Regulators, Scientific & Medical Leaders Convene to Discuss Pressing Issues Facing 30 Million Americans with a Rare Disease
WASHINGTON, Oct. 12, 2023 /PRNewswire/ --
WHAT: |
Join the National Organization for Rare Disorders (NORD) Oct. 15-17, 2023 in Washington for the |
The two-day event will focus on critical topics faced in diagnosing and finding treatments for |
|
WHO: |
-Peter Saltonstall, President and Chief Executive Officer, NORD |
-Robert Califf, MD, Commissioner, U.S. Food and Drug Administration |
|
Special CEO Perspectives Panel: Outlook for Rare Diseases and Orphan Products |
|
-R. Duane Clark, General Manager, U.S. Rare Diseases, Sanofi |
|
-Eric Dube, Ph.D., President and Chief Executive Officer, Travere |
|
-Myrtle Potter, President and Chief Executive Officer, Sumitomo Pharma America |
|
-Brigette Roberts, M.D., OrphAI Therapeutics |
|
-Stephen Uden, M.D., Co-Founder and Chief Executive Officer, Rallybio |
|
WHEN/WHERE: |
Oct. 16-17, 2023, Marriot Marquis, Washington |
Livestream is available upon request |
|
WHY: |
Rare disease is a public health challenge. From small towns to large cities, more than 30 million |
SOURCE National Organization for Rare Disorders (NORD)
![](https://rt.prnewswire.com/rt.gif?NewsItemId=DC36502&Transmission_Id=202310120915PR_NEWS_USPR_____DC36502&DateId=20231012)
Share this article